IS-6 Growth Suppression of A Cervical Cancer Cell Line (TMCC-1) by Human Wild Type p53 Gene
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本産科婦人科学会の論文
- 1995-02-20
著者
-
Iwasaka T.
Saga Medicai School
-
Zheng P-S.
Saga Medical School
-
Matsuo N.
Saga Medical School
-
Yokoyama M.
Saga Medical School
-
Fukuda K.
Saga Medical School
-
Nakamura S.
Saga Medical School
-
Sugimori H.
Saga Medical School
-
Zheng P-s.
Saga Medicai School
-
Sugimori H.
Saga Medicai School
-
Iwasaka T.
Saga Medical School
-
Yokoyama M.
Saga Medicai School
-
Fukuda K.
Saga Medicai School
-
Sugimori H.
Saga Med. Sch.
関連論文
- IS-6 Growth Suppression of A Cervical Cancer Cell Line (TMCC-1) by Human Wild Type p53 Gene
- IS-2 PREVALENCE OF HPV TYPES 16 AND 18 IN CERVICAL CARCINOMA IN ZAIRE
- IS-38 Cytological Changes in Two Cervical carcinoma cell lines after Transfection of The Wild Type p53 Gene
- 11 Analysis of expression of c-myc and Ha-ras oncogenes in invasive cervical carcinoma.
- 22 Detection of Human papillomavirus DNA and Antitumor effect of Cytokines on Cervical adenocarcinoma cell lines.
- 3 Detection of Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uteirne cervix.
- 100 Expression of Lectin and Blood Group Antigens of the Ovarian epithelial tumors.
- 9 Follow up study of the cervical human papilloma virus infection in the women with cervical intraepithelial neophasia (CIN).
- 83 Immunohistochemical observation of Langerhans cells and tumorinfiltrating lymphocytes in invasive squamous cell carcinoma of the cervix.
- 62 Tumorigenic transformation of primary cells by human papillomavirus types 16 and 18.
- 305 Immunohistochemical observation of the Langerhans cells in squamous cell carcinoma of the uterine cervix.
- 14 Oncogenic transformation by HPV 16 or HPV 18 : The possibility of "hit and run" oncogenesis.
- 516. Combined Herpes Simplex Virus Type 2 and Human Papilloma Virus 16 or 18 DNA Leads to Oncogenic Transformation
- 20. Immunohistochemical Demonstration of Histiocytes in Normal Ectocervical Epithelium and Epithelial Lesions of the Uterine Cervix
- 8. Immunocytochemical Detection of S-phase Cells in Gynecologic Malignancies Using anti-BrdU Monoclonal Antibody
- 2. Overexpression of ras p21 and Epidermal Growth Factor Receptor in Cervical Cancer
- 372. Tryptic Peptide Analysis of Cervical Tumor Assodiated Antigen AG-4 (ICP-1O)
- 111. Immunohistochemical Localization of Carcinoembryonic Antigen (CEA) and Lectin in Adenocarcinoma of the Endocervix and the Endometrium
- 388 Microcarcinomas and severe atypical focus of the endometrium.
- 302. Usefulness of Digital Subtraction Angiography as a Subsidiary Diagnosis for the Gynecological Disease
- 124.Quantitative Differencial Diagnosis between Endometrial Carcinoma and its Borderline Groups : XXI Malignant Tumor(I)
- 194 Effect of methylergometrine maleate (methergin) on electrical and mechanical activities of pregnant human myometrium.
- 229. The Analysis of Fetal Heart Rate Fluctuation by Autoregressive Model
- 371. Malignant,Transformation and Expression of Oncogene by the Fragment of Herpes Simplex Virus Type 2 DNA that Encodes ICP 10 (AG-4)
- 195. The Study of the Syncronization of Uterine Contractions Recorded by the Guard-ring Tocodynamometer
- 23 Examination of lymphoma-like lesion of the uterine cervix.